Improving Diagnosis and Prediction of Outcome in Patients With Severe Disorders of Consciousness

Last updated: February 22, 2024
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Overall Status: Active - Recruiting

Phase

N/A

Condition

Traumatic Brain Injury

Meningitis

Stroke

Treatment

N/A

Clinical Study ID

NCT06283901
NL82013.018.22
  • Ages > 18
  • All Genders

Study Summary

Patients with acute severe brain injury are usually admitted to the Intensive Care Unit. A substantial proportion of these patients will have disorders of consciousness (DOC) after interruption of sedation. It is difficult to reliably predict neurological outcome in these patients. Dependent on the extent of permanently damaged brain areas, DOC in patients with acute severe brain injury may improve or persist, eventually evolving into a minimal conscious state (MCS) or unresponsive wakefulness syndrome (UWS). These conditions are accompanied by long term severe disability. In current practice, the decision to withdraw life-sustaining support is made by interpreting the results of repeated bedside neurological examination and conventional CT-brain imaging. Reliable identification of patients with a possible good outcome, in whom treatment should not be withdrawn, is difficult. In this prospective observational cohort study we aim to identify patients with a good neurological outcome.

Eligibility Criteria

Inclusion

Inclusion Criteria: All patients that are admitted to the ICU with the following criteria will be eligible forinclusion:

  1. Severe brain injury (GCS ≤ 8) as a result of:
  2. Traumatic brain injury
  3. Ischemic cerebrovascular accident
  4. Intracranial hemorrhage
  5. Meningo-encephalitis
  6. Subarachnoid hemorrhage
  7. Age ≥ 18 years old
  8. Written informed consent from legal representatives

Exclusion

Exclusion Criteria: A potential subject who meets any of the following criteria will be excluded fromparticipation in this study:

  • Absence of informed consent
  • Moribund at ICU admission
  • Progressive neurodegenerative disease
  • Pre-admission life expectancy ≤ 6 months based on comorbidity
  • GCS has been > 8 prior to inclusion
  • Impossible to include within 24 hours after brain injury

Study Design

Total Participants: 160
Study Start date:
January 02, 2023
Estimated Completion Date:
September 01, 2025

Study Description

In order to identify patients with a good neurological outcome a combination of diagnostic tests is used.

Clinical rating scales

  • Simplified evaluation of consciousness scale (SECONDs) and the full outline of unresponsiveness (FOUR) score

  • Once a week

Blood biomarkers

  • Neuron specific enolase, neurofilament light, glial fibrillary acidic protein

  • Sampling timepoints: 24h, 72h, 7 days and 14 days after brain injury

  • Serum (STG-5) and plasma (EDTA-6) tubes, aliquoted (4 x 0.5ml) and stored at -80°C

EEG with reactivity testing

  • Standard 21-electrode montage

  • Stimuli protocol I: a set of 5 stimuli repeated 3 times

    1. Auditory: clapping in hands, 2. Auditory: calling patients name loudly, 3. Visual: passive eye opening, 4. Tactile: nasal tickle, 5. Noxious: sternal rub Each stimuli is applied for a duration of 5 seconds and an interval between stimuli of 30 seconds
  • Stimuli protocol II: Cognitive-motor dissociation test

MRI-scan

  • Sequences considered essential for patient care i.e.T1, T2, FLAIR, DWI/SWI

  • Preferably, performed between 4-6 weeks after hospital admission

Connect with a study center

  • Radboud UMC

    Nijmegen, Gelderland 6525 GA
    Netherlands

    Active - Recruiting

  • Amsterdam UMC

    Amsterdam, Noord-Holland 1105 AZ
    Netherlands

    Active - Recruiting

  • Haaglanden MC, locatie Westeinde

    Den Haag, Zuid-Holland 2512 VA
    Netherlands

    Active - Recruiting

  • Erasmus MC

    Rotterdam, Zuid-Holland 3015 GD
    Netherlands

    Site Not Available

  • UMC Groningen

    Groningen, 9713 GZ
    Netherlands

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.